- Report
- April 2024
- 125 Pages
Global
From €2584EUR$2,963USD£2,251GBP
€3446EUR$3,950USD£3,001GBP
- Report
- February 2024
- 140 Pages
Global
From €2780EUR$3,188USD£2,421GBP
€3707EUR$4,250USD£3,229GBP
- Report
- January 2024
- 143 Pages
Global
From €2780EUR$3,188USD£2,421GBP
€3707EUR$4,250USD£3,229GBP
- Report
- November 2024
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- July 2024
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- July 2024
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- April 2023
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- January 2025
- 248 Pages
Global
From €4357EUR$4,995USD£3,795GBP
- Report
- March 2024
- 171 Pages
North America
€4357EUR$4,995USD£3,795GBP
- Report
- February 2024
- 380 Pages
Global
€4357EUR$4,995USD£3,795GBP
- Report
- January 2024
- 227 Pages
Global
€4357EUR$4,995USD£3,795GBP
- Report
- February 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- December 2024
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- January 2024
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- January 2024
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- March 2023
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- February 2026
China
From €3480EUR$3,990USD£3,031GBP
- Report
- February 2026
United Kingdom
From €3480EUR$3,990USD£3,031GBP
- Report
- January 2025
- 73 Pages
Global
From €3500EUR$4,298USD£3,155GBP
- Report
- January 2025
- 83 Pages
Global
From €3500EUR$4,298USD£3,155GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more